BCAL Diagnostics Limited is an Australia-based biotechnology company dedicated to...BCAL Diagnostics Limited is an Australia-based biotechnology company dedicated to advancing early and accurate breast cancer detection. The Company’s core activity is the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, which is available to all women. Its non-invasive blood test, BREASTEST plus, is the product in the Company’s BREASTEST range of non-invasive, lipid-based breast cancer diagnostics. BREASTEST plus is a class blood test that measures a panel of lipids, using Liquid Chromatography Mass Spectrometry, to identify a lipidomic breast cancer signature. BREASTEST plus is a rule-out test that has been designed to be used in women with dense breasts and alongside mammography to improve screening and diagnostic outcomes for women.More
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
ASX News
